advances and opportunities to address co-infections: cmv retinitis and hepatitis c
DESCRIPTION
Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C. IAS 2013 Sunday 30 July. Why Co-Infections…?. Co-infections remain important despite the success of ART roll out Late presenters - CMV Important co-infection even in face of ART - HCV - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C](https://reader035.vdocuments.us/reader035/viewer/2022062222/5681672e550346895ddbd3d5/html5/thumbnails/1.jpg)
Advances and Opportunities to Address Co-Infections:
CMV Retinitis and Hepatitis CIAS 2013
Sunday 30 July
![Page 2: Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C](https://reader035.vdocuments.us/reader035/viewer/2022062222/5681672e550346895ddbd3d5/html5/thumbnails/2.jpg)
Why Co-Infections…?Co-infections remain important despite the success
of ART roll outLate presenters - CMV Important co-infection even in face of ART - HCV
Need for additional political will and fundingTesting and treatment often not supportedFew guidelinesRegional importance
Key opportunitiesCMV: Potential for decentralization of screening,
diagnosis and treatmentHCV: Potential for paradigm shifting pipeline regimens
![Page 3: Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C](https://reader035.vdocuments.us/reader035/viewer/2022062222/5681672e550346895ddbd3d5/html5/thumbnails/3.jpg)
Goals: CMV and HCVExamine burden Explore challenges in
diagnosis and treatment
Share MSF experienceHighlight critical and
timely opportunities to improve access to diagnosis, treatment and care
![Page 4: Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C](https://reader035.vdocuments.us/reader035/viewer/2022062222/5681672e550346895ddbd3d5/html5/thumbnails/4.jpg)
AgendaCMV Retinitis – the neglected co-infection
Khin Nyein Chan, Nathan Ford Peter Saranchuk Arax Bozadjian**Respondant: Dr. Rewari
Hepatitis C – Increasing recognition of importance Nicolas Durier Isabelle Andrieux-Meyer Manica Balasegaram**Respondant: Shiba Phurailatpam